九典制药撤回吲哚美辛凝胶贴膏药品注册申请

Core Viewpoint - Jiutian Pharmaceutical has received approval from the National Medical Products Administration to withdraw its drug registration application for indomethacin gel patch due to the need for further improvement of related experimental data [1] Group 1 - The company announced the withdrawal of its drug registration application for indomethacin gel patch on December 17 [1] - The decision to withdraw the application was made after communication with the National Medical Review Center [1] - The company plans to supplement and improve the relevant research before restarting the registration application process [1]